Beyond TP53 mutation: transcriptional regulation of the p53 pathway in pediatric AML
Klinische Pädiatrie · 01.05.2026 · 238 (03) · e14
DOI: 10.1055/s-0046-1822737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2026. Verfasst von L N Cifarelli und 5 weiteren Autor:innen.
Abstract (Originalsprache)
TP53 is a central tumor suppressor, yet TP53 mutations are rare in pediatric acute myeloid leukemia (AML), suggesting that p53 dysfunction may arise through non-mutational mechanisms. In this study, we investigated the clinical relevance of TP53 expression and TP53-related regulatory programs in pediatric AML using transcriptomic and survival data from independent patient cohorts. Kaplan-Meier analyses showed that TP53 mRNA expression alone was not associated with outcome in pediatric AML, whereas a distinct pattern was observed in adult AML, highlighting important context-dependent differences in TP53 pathway regulation. To move beyond single-gene analyses, we examined TP53-related gene sets and identified pathway signatures associated with adverse prognosis in pediatric AML. These findings support the hypothesis of p53-network dysfunction in pediatric AML through altered tumorsuppressor networks rather than TP53 mutation or abundance alone. Overall, this work provides a framework to better understand TP53 pathway regulation in pediatric AML and to identify candidate mechanisms underlying disease progression. Publication History Article published online: 21 May 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Cifarelli, L. N., Gonçalves-Dias, J., Salzmann-Manrique, E., Schuschel, K., Klusmann, J., & Heckl, D. (2026). Beyond TP53 mutation: transcriptional regulation of the p53 pathway in pediatric AML. Klinische Pädiatrie, 238(03), e14. https://doi.org/10.1055/s-0046-1822737
Vancouver
Cifarelli LN, Gonçalves-Dias J, Salzmann-Manrique E, Schuschel K, Klusmann J, Heckl D. Beyond TP53 mutation: transcriptional regulation of the p53 pathway in pediatric AML. Klinische Pädiatrie. 2026;238(03):e14. doi:10.1055/s-0046-1822737
BibTeX
@article{Cifarelli2026,
author = {Cifarelli, L N and Gonçalves-Dias, J and Salzmann-Manrique, E and Schuschel, K and Klusmann, J-H and Heckl, D},
title = {Beyond TP53 mutation: transcriptional regulation of the p53 pathway in pediatric AML},
journal = {Klinische Pädiatrie},
year = {2026},
volume = {238},
number = {03},
pages = {e14},
doi = {10.1055/s-0046-1822737}
}
EUVIMED